Entrada Therapeutics, Inc. · NASDAQ:TRDA
BlackRock, Inc. reported a 5.30% stake in Entrada Therapeutics, Inc. (Schedule 13G)
Event Dec 31, 2024 · Filed Feb 4, 2025
BlackRock, Inc. reported a 5.30% stake in Entrada Therapeutics, Inc., 1,974,452 shares, as a passive investor on Dec 31, 2024. Filed Feb 4, 2025 (Schedule 13G).
- Stake
- 5.30%
- Shares
- 1,974,452
- Intent
- Passive
- What changed
- Crossed above 5%
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| BlackRock, Inc. | 5.30% | 1,974,452 |
Source
Related
- Entrada Therapeutics, Inc.
- BlackRock, Inc.
- Entrada Therapeutics, Inc. shareholders
- Schedule 13D/A · Ansbert Gadicke · Sep 10, 2026
- Form 4 · MPM BioVentures 2018 GP LLC · Sep 9, 2026
- Form 4 · Mpm Bioventures 2018 (B), L.P. · Sep 9, 2026
- Form 4 · MPM BioVentures 2018 LLC · Sep 3, 2026
- Form 4 · MPM BioVentures 2014 GP LLC · Sep 3, 2026